OTCMKTS:YEWB

Yew Bio-Pharm Group Stock Forecast, Price & News

$0.20
+0.04 (+25.00 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.15
Now: $0.20
$0.20
50-Day Range
$0.12
MA: $0.15
$0.17
52-Week Range
$0.02
Now: $0.20
$0.29
Volume8,100 shs
Average Volume5,956 shs
Market Capitalization$10.34 million
P/E Ratio12.00
Dividend YieldN/A
Beta-1.02
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China and the United States. It offers traditional Chinese medicine (TCM) raw materials in the form of yew tree branches and leaves to manufacture TCM containing taxol. The company is also involved in processing and selling yew raw materials used in the manufacture of traditional Chinese medicine; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber; selling agricultural products, such as yew candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps; and selling wood ear mushroom. In addition, it engages in the marketing and sale of cosmetics. The company was incorporated in 2007 and is based in El Monte, California.

Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
Current SymbolOTCMKTS:YEWB
CUSIPN/A
Phone626-401-9588
Employees35
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.88 million
Cash Flow$0.09 per share
Book Value$0.80 per share

Profitability

Net Income$990,000.00

Miscellaneous

Market Cap$10.34 million
Next Earnings Date7/5/2021 (Estimated)
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

1.02 out of 5 stars

Consumer Staples Sector

154th out of 301 stocks

Agricultural Production - Crops Industry

9th out of 21 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -
$0.20
+0.04 (+25.00 %)
(As of 04/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive YEWB News and Ratings via Email

Sign-up to receive the latest news and ratings for YEWB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Yew Bio-Pharm Group (OTCMKTS:YEWB) Frequently Asked Questions

What stocks does MarketBeat like better than Yew Bio-Pharm Group?

Wall Street analysts have given Yew Bio-Pharm Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Yew Bio-Pharm Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Yew Bio-Pharm Group's next earnings date?

Yew Bio-Pharm Group is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for Yew Bio-Pharm Group
.

How were Yew Bio-Pharm Group's earnings last quarter?

Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) posted its quarterly earnings data on Tuesday, August, 14th. The company reported $0.03 earnings per share (EPS) for the quarter. The company earned $14.82 million during the quarter. Yew Bio-Pharm Group had a trailing twelve-month return on equity of 0.15% and a net margin of 0.40%.
View Yew Bio-Pharm Group's earnings history
.

How has Yew Bio-Pharm Group's stock been impacted by Coronavirus (COVID-19)?

Yew Bio-Pharm Group's stock was trading at $0.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, YEWB stock has increased by 66.7% and is now trading at $0.20.
View which stocks have been most impacted by COVID-19
.

Who are Yew Bio-Pharm Group's key executives?

Yew Bio-Pharm Group's management team includes the following people:
  • Mr. Zhiguo Wang, Founder, CEO, Pres, Interim CFO & Chairman (Age 59, Pay $27.82k)
  • Madam Guifang Qi, Sec. & Director (Age 59, Pay $69.6k)
  • Mr. Xingming Han, Gen. Mang. of Harbin Yew Science and Technology Devel. Co Ltd (Age 56)

Who are some of Yew Bio-Pharm Group's key competitors?

What is Yew Bio-Pharm Group's stock symbol?

Yew Bio-Pharm Group trades on the OTCMKTS under the ticker symbol "YEWB."

How do I buy shares of Yew Bio-Pharm Group?

Shares of YEWB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Yew Bio-Pharm Group's stock price today?

One share of YEWB stock can currently be purchased for approximately $0.20.

How much money does Yew Bio-Pharm Group make?

Yew Bio-Pharm Group has a market capitalization of $10.34 million and generates $27.88 million in revenue each year.

How many employees does Yew Bio-Pharm Group have?

Yew Bio-Pharm Group employs 35 workers across the globe.

What is Yew Bio-Pharm Group's official website?

The official website for Yew Bio-Pharm Group is www.yewbiopharm.com.

Where are Yew Bio-Pharm Group's headquarters?

Yew Bio-Pharm Group is headquartered at 9460 Telstar Avenue Suite 6, El Monte CA, 91731.

How can I contact Yew Bio-Pharm Group?

Yew Bio-Pharm Group's mailing address is 9460 Telstar Avenue Suite 6, El Monte CA, 91731. The company can be reached via phone at 626-401-9588 or via email at [email protected]


This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.